Kasia J Lipska

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi request reprint WITHDRAWN: Promoting the use of DPP-4 inhibitors in Asia
    Kasia J Lipska
    Fogarty International Clinical Research Fellow, Public Health Foundation of India PHFI, New Delhi, India Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA Electronic address
    Diabetes Res Clin Pract . 2012
  2. pmc Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013
    Kasia J Lipska
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
    Diabetes Care . 2016
  3. pmc HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study
    Kasia J Lipska
    Corresponding author Kasia J Lipska
    Diabetes Care 36:3535-42. 2013
  4. pmc Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults: are two better than one?
    Kasia J Lipska
    Corresponding author Kasia J Lipska
    Diabetes Care 36:3923-9. 2013
  5. doi request reprint Glucose variability and mortality in patients hospitalized with acute myocardial infarction
    Kasia J Lipska
    Department of Internal Medicine, Yale University, New Haven, CT, USA
    Circ Cardiovasc Qual Outcomes 5:550-7. 2012
  6. doi request reprint Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes
    Kasia J Lipska
    Department of Medicine, Yale University School of Medicine, New Haven, CT 06520 8088, USA
    Circ Cardiovasc Qual Outcomes 3:236-42. 2010
  7. pmc Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c
    Kasia J Lipska
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, P O Box 208088, 333 Cedar Street, SHM IE 61, New Haven, Connecticut 06520 8088, USA
    J Clin Endocrinol Metab 95:5289-95. 2010
  8. pmc National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011
    Kasia J Lipska
    Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut
    JAMA Intern Med 174:1116-24. 2014
  9. ncbi request reprint Management of blood glucose in patients with acute coronary syndromes
    Kasia J Lipska
    Yale University School of Medicine, New Haven, CT, USA
    Rev Cardiovasc Med 13:e77-88. 2012
  10. ncbi request reprint Hypoglycemia and adverse outcomes: marker or mediator?
    Kasia J Lipska
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, USA
    Rev Cardiovasc Med 12:132-5. 2011

Detail Information

Publications14

  1. doi request reprint WITHDRAWN: Promoting the use of DPP-4 inhibitors in Asia
    Kasia J Lipska
    Fogarty International Clinical Research Fellow, Public Health Foundation of India PHFI, New Delhi, India Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA Electronic address
    Diabetes Res Clin Pract . 2012
    ..The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy...
  2. pmc Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013
    Kasia J Lipska
    Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
    Diabetes Care . 2016
    ..To examine temporal trends in utilization of glucose-lowering medications, glycemic control, and rate of severe hypoglycemia among patients with type 2 diabetes (T2DM)...
  3. pmc HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study
    Kasia J Lipska
    Corresponding author Kasia J Lipska
    Diabetes Care 36:3535-42. 2013
    ..We examined the association between HbA1c level and self-reported severe hypoglycemia in patients with type 2 diabetes...
  4. pmc Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults: are two better than one?
    Kasia J Lipska
    Corresponding author Kasia J Lipska
    Diabetes Care 36:3923-9. 2013
    ..To determine which measures-impaired fasting glucose (IFG), elevated HbA1c, or both-best predict incident diabetes in older adults...
  5. doi request reprint Glucose variability and mortality in patients hospitalized with acute myocardial infarction
    Kasia J Lipska
    Department of Internal Medicine, Yale University, New Haven, CT, USA
    Circ Cardiovasc Qual Outcomes 5:550-7. 2012
    ..Whether GV is associated with in-hospital mortality during AMI, after accounting for mean BG, is unknown...
  6. doi request reprint Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes
    Kasia J Lipska
    Department of Medicine, Yale University School of Medicine, New Haven, CT 06520 8088, USA
    Circ Cardiovasc Qual Outcomes 3:236-42. 2010
    ..We examined the frequency of this practice and evaluated the associated outcomes of readmission and mortality...
  7. pmc Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c
    Kasia J Lipska
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, P O Box 208088, 333 Cedar Street, SHM IE 61, New Haven, Connecticut 06520 8088, USA
    J Clin Endocrinol Metab 95:5289-95. 2010
    ..Hemoglobin A1c (A1c) was recently added to the diagnostic criteria for diabetes and prediabetes...
  8. pmc National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011
    Kasia J Lipska
    Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut
    JAMA Intern Med 174:1116-24. 2014
    ..Trends in these hospitalizations and subsequent outcomes are not known...
  9. ncbi request reprint Management of blood glucose in patients with acute coronary syndromes
    Kasia J Lipska
    Yale University School of Medicine, New Haven, CT, USA
    Rev Cardiovasc Med 13:e77-88. 2012
    ..This article reviews data from observational studies and clinical trials and synthesizes this information into practical recommendations based on available evidence...
  10. ncbi request reprint Hypoglycemia and adverse outcomes: marker or mediator?
    Kasia J Lipska
    Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, USA
    Rev Cardiovasc Med 12:132-5. 2011
    ..Nevertheless, continued efforts to avoid hypoglycemia are clearly warranted...
  11. pmc Potential overtreatment of diabetes mellitus in older adults with tight glycemic control
    Kasia J Lipska
    Section of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut
    JAMA Intern Med 175:356-62. 2015
    ..In older adults with multiple serious comorbidities and functional limitations, the harms of intensive glycemic control likely exceed the benefits...
  12. pmc Risk-standardized Acute Admission Rates Among Patients With Diabetes and Heart Failure as a Measure of Quality of Accountable Care Organizations: Rationale, Methods, and Early Results
    Erica S Spatz
    Section of Cardiovascular Medicine, Yale University School of Medicine Center for Outcomes Research and Evaluation, Yale New Haven Hospital Sections of Endocrinology General Internal Medicine Departments of Internal Medicine, Robert Wood Johnson Foundation Clinical Scholars Program Health Policy and Management Pediatrics, Yale University School of Medicine, New Haven, CT
    Med Care 54:528-37. 2016
    ....
  13. pmc Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes
    Kasia J Lipska
    Department of Internal Medicine, Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut
    JAMA 315:1034-45. 2016
    ..There is substantial uncertainty about optimal glycemic control in older adults with type 2 diabetes mellitus...
  14. pmc Metformin in patients with type 2 diabetes and kidney disease: a systematic review
    Silvio E Inzucchi
    Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut
    JAMA 312:2668-75. 2014
    ..However, the drug is contraindicated in many individuals with impaired kidney function because of concerns of lactic acidosis...